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Abstract 23 
Objective: Metabolically healthy obesity possibly reflects a transitional stage before the 24 
onset of metabolic dysfunction, but few studies have characterised this transition. We 25 
examined the behavioural and biological characteristics of healthy obese adults that 26 
progressed to an unhealthy state over 8 years follow up. 27 
Methods: Participants were 2422 men and women (aged 63.3 ± 7.7 years, 44.2% men) from 28 
the English Longitudinal Study of Ageing. Obesity was defined as body mass index ≥ 30 29 
kg/m2. Based on blood pressure, HDL-cholesterol, triglycerides, glycated haemoglobin, and 30 
C-reactive protein participants were classified as ‘healthy’ (0 or 1 metabolic abnormality) or 31 
‘unhealthy’ (≥ 2 metabolic abnormalities). 32 
Results: Over eight years follow-up, 44.5% of healthy obese had transitioned into an 33 
unhealthy state, compared to only 16.6% and 26.2% of healthy normal weight and 34 
overweight adults, respectively. Compared with healthy obese adults who remained stable, 35 
those who progressed to an unhealthy state were more likely to have high blood pressure 36 
(75.0% vs 37.0%, age- and sex-adjusted odds ratio [OR] 8.9, 95% confidence interval [CI] 4.7-37 
17.0), high C-reactive protein (53.7% vs 17.0%, OR=8.6, 95% CI 4.1-18.0), high glycated 38 
haemoglobin (46.3% vs 5.9%, OR=13.8, 95% CI 6.1-31.2) and high triglycerides (45.4% vs 39 
11.9%, OR=5.9, 95% CI 2.9-12.0) at follow-up, with excess risk remaining independent of 40 
lifestyle factors including self-reported physical activity. Progression to an unhealthy state 41 
was also linked with significant gains in waist circumference (B=2.7, 95% CI, 0.5 – 4.9 cm).  42 
Conclusion:  These data show that a healthy obesity phenotype is relatively unstable. 43 
Transition to an unhealthy state is characterised by multiple biological changes which are 44 
not fully explained by lifestyle risk factors. 45 
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Introduction  46 
Population based studies have identified an obese phenotype that is not accompanied by 47 
adiposity associated cardio-metabolic risk factors. Termed ‘metabolically healthy obesity’, it 48 
is unclear if the healthy obese phenotype is a stable trait or a transitional stage prior to the 49 
onset of metabolic dysfunction.1 This instability may explain the inconsistency in findings 50 
between studies with shorter and longer follow-up periods in relation to healthy obesity and 51 
risk of incident type 2 diabetes and cardiovascular disease (CVD).2,3 52 
In particular, the characteristics of healthy obese participants that remain stable or develop 53 
metabolic abnormalities are poorly understood. In a recent cohort study, 67% of healthy 54 
obese adults maintained stable metabolic health profiles at 4 years follow-up, and these 55 
adults displayed lower waist circumference at baseline although no differences in physical 56 
activity, alcohol or smoking were observed.4 In the Whitehall II study of British men and 57 
women, more than half of healthy obese adults progressed to an unhealthy obese state 58 
after 20 years.5 The aim of the present study was to examine stability of healthy obesity 59 
over an 8 year follow-up period and to describe the metabolic and lifestyle profile of obese 60 
participants that progressed to an unhealthy state. 61 
 62 
Materials and Methods 63 
Study sample and procedures 64 
The English Longitudinal Study of Ageing (ELSA) is an ongoing cohort study that contains a 65 
nationally representative sample of free-living men and women born on or before 29 66 
February 1952.6 Data collected at wave 2 (2004-05) were used as the baseline for present 67 
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analyses, as this was the first occasion clinical information was gathered. A clinical 68 
assessment was repeated eight years later. Participants gave full informed written consent 69 
to participate in the study and ethical approval was obtained from the London Multi-Centre 70 
Research Ethics Committee.  71 
Clinical Measurements at baseline and follow-up 72 
Nurses collected anthropometric data (weight, height, waist circumference), blood pressure 73 
(BP), and non-fasting blood samples using standard protocols at baseline and follow-up. 74 
Body weight was measured using Tanita electronic scales without shoes and in light 75 
clothing, and height was measured using a Stadiometer with the Frankfort plane in the 76 
horizontal position. Body mass index (BMI) was calculated as weight (kilograms)/height 77 
(meters) squared. Waist circumference was recorded twice mid-way between the iliac crest 78 
and lower rib using measuring tape. An average of the first two measurements was used 79 
provided these differed by no more than 3cm; otherwise a third reading was taken and the 80 
two closest results utilised. Systolic and diastolic BP was measured with an Omron HEM-907 81 
blood pressure monitor three times in the sitting position after 5-minute rest between each 82 
reading. The initial reading was discarded and an average of the second and third BP 83 
recordings was used for the present analyses. Blood samples were analyzed for C-reactive 84 
protein (CRP), high density lipoprotein (HDL) cholesterol, triglycerides, and glycated 85 
haemoglobin (HbA1c). Detailed information on the technicalities of the blood analysis, the 86 
internal quality control, and the external quality assessment for the laboratory have been 87 
described elsewhere.7 Additional data were collected on physician diagnosed conditions 88 
(hypertension, diabetes) and medication use. 89 
Lifestyle risk factors at baseline 90 
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Health-related questions included cigarette smoking (current, previous or non-smoker), the 91 
frequency of participation in light, moderate, and vigorous physical activities (more than 92 
once per week, once per week, one to three times per month, hardly ever), and the 93 
frequency of alcohol intake (daily, 5-6/week, 3-4/week, 1-2/week, 1-2/month, once every 94 
couple of months, 1-2/year, never).  95 
Statistical analyses 96 
We used the conventional criteria to define obesity (BMI ≥ 30 kg/m2) and overweight (BMI ≥ 97 
25 and <30 kg/m2). A healthy metabolic status was based on existing criteria,8 and according 98 
to availability of data, defined as having less than two of the following metabolic risk factors: 99 
high BP (BP ≥130/85 mmHg, or hypertension diagnosis, or use of anti-hypertensive 100 
medication), impaired glycaemic control (HbA1c > 6.0% [42.1 mmol/mol] or doctor’s 101 
diagnosed diabetes), systemic inflammation (CRP≥ 3mg/l), low HDL cholesterol (<1.03 102 
mmol/l in men and <1.30 mmol/l in women), and high triacylglycerol (≥ 1.7 mmol/l). 103 
Participants were then categorized into four groups:  ‘healthy non-obese’; ‘unhealthy non-104 
obese’; ‘healthy obese ’; and ‘unhealthy obese’. We categorised healthy obese participants 105 
into those that met criteria for healthy obesity both at baseline and at 8 years follow-up 106 
(‘stable healthy obese’) and those that developed ≥ 2 metabolic risk factors (‘unstable 107 
healthy obese’). Differences in baseline characteristics between stable and unstable groups 108 
were tested using ANOVA and Chi-squared tests. Metabolic profiles at follow-up between 109 
stable and unstable groups were compared using logistic regression and general linear 110 
models to examine individual risk factors as categorical and continuous variables, 111 
respectively. In multivariable models we adjusted effect estimates for several covariates in a 112 
step-wise fashion: Model 1 contained age, sex, and baseline risk factor; Model 2 contained 113 
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additional behavioural and anthropometric covariates, including baseline smoking, alcohol, 114 
physical activity, and change in central obesity (waist circumference). We also examined the 115 
concept of ‘weight cycling’, which was defined as participants who experienced both weight 116 
gain (>5% gain in BMI) and weight loss (>5% reduction BMI) between examinations.9 For 117 
these analyses we utilised data collected from baseline (wave 2; 2004-05), wave 4 (2008-118 
09), and wave 6 (2012-13). Analyses were conducted using SPSS version 20. 119 
 120 
Results 121 
At baseline the sample consisted of 3851 individuals although loss to follow up resulted in a 122 
final analytic sample of 2442 men and women (aged 63.3 ± 7.7 yrs, 44.2% men). Participants 123 
excluded (drop-outs) did not differ in age, gender, or BMI, but were less physically active 124 
(23.8 vs 13.5%, p<0.001) and more likely to be metabolically unhealthy (46.2 vs 40.6% ≥ 2 125 
risk factors, p=0.001) compared with included participants, respectively. 126 
At baseline, 1206 participants were classified as healthy non-obese, 584 as unhealthy non-127 
obese, 243 as healthy obese, and 389 as unhealthy obese. At follow-up, 44.5% of baseline 128 
healthy obese adults had transitioned into an unhealthy state, compared with 22% of 129 
healthy non-obese adults (Figure 1). We further categorised the non-obese into ‘healthy 130 
normal weight’ (n=530) and ‘healthy overweight’ (n=676); 16.6% and 26.2%, respectively, 131 
had transitioned into an unhealthy state at follow up. Adjusting for age and sex, healthy 132 
obese adults were four times as likely to transition into an unhealthy state compared with 133 
healthy normal weight adults (odds ratio = 4.00, 95% CI, 2.81 – 5.69). As expected, this 134 
association was weaker when the healthy obese were compared with the healthy 135 
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overweight (odds ratio = 2.30, 95% CI, 1.69 – 3.13). This likelihood remained unchanged 136 
after further adjustment for baseline lifestyle risk factors, including self reported physical 137 
activity, in relation to healthy normal weight (odds ratio=3.79, 95% CI, 2.60–5.51) or 138 
overweight (odds ratio = 2.30, 95% CI, 1.66 – 3.19) as the reference category. At baseline, 139 
656 participants (n=70 healthy obese) had exceptional metabolic health (zero risk factors; 140 
10.7% of obese adults vs 32.7% of non-obese adults). At follow-up, 325 (55.5%) of healthy 141 
non-obese and 19 (27.1%) of healthy obese remained free of any risk factors. 142 
There were no differences in demographic and behavioural characteristics between stable 143 
and unstable healthy obese adults at baseline, although a higher proportion of stable 144 
participants had zero risk factors and stable healthy obese displayed higher baseline levels 145 
of HDL-cholesterol, and lower triacylglycerol, and HbA1c (Table 1). At follow-up, all 146 
metabolic risk factors were more prevalent among unstable healthy obese compared with 147 
stable participants. Compared with healthy obese adults that remained stable, those that 148 
progressed to an unhealthy state also gained greater waist circumference at follow up 149 
(B=2.7; 95% CI, 0.5, 4.9 cm), although no increase in BMI was observed (B= 0.63; -0.02, 1.28 150 
kg/m2) after baseline adjustment. In the overall cohort 9.3% of study members were 151 
identified as ‘weight cycling’, although this was not associated with stability of metabolic 152 
health. Lifestyle risk factors remained similar at follow-up between stable and unstable 153 
healthy obese; for example, participation in vigorous physical activity (25.8% vs. 31.1%, 154 
p=0.43) and smoking (2.3% vs. 5.7%, p= 0.33) was comparable in stable and unstable, 155 
respectively, at follow-up. When we compared the characteristics of stable and unstable 156 
healthy overweight participants the results we largely similar to those presented for the 157 
healthy obese group. 158 
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Unstable healthy obese adults demonstrated higher HbA1c (B=0.22; 0.14, 0.30%), higher 159 
triglycerides (B=0.31; 0.16, 0.47 mmol/L), higher CRP (B=0.34; 0.20, 0.47 log units), and 160 
lower HDL cholesterol (B= -0.12; -0.19, -0.06mmol/L) at follow-up after baseline 161 
adjustments for each respective risk factor. When we adjusted these models for change in 162 
waist circumference the associations with HbA1c were marginally attenuated (B=0.19; 0.12, 163 
0.27) but effect estimates for other biomarkers were unchanged. Further adjustments for 164 
lifestyle risk factors at baseline or follow-up did not influence the associations (data 165 
available on request). 166 
We further examined the characteristics of unhealthy obese adults at baseline who 167 
remained unhealthy or became healthy at follow-up (Table 2). At follow-up, 23.1% of 168 
unhealthy obese had transitioned into a healthy state. There were few differences in 169 
baseline characteristics between those that remained unhealthy and became healthy, 170 
except that participants transitioning into a healthy state were more likely to consume 171 
alcohol regularly (Table 2). Compared with unhealthy obese adults that became healthy, 172 
those that remained unhealthy gained greater waist circumference (B=5.5; 95% CI, 3.3, 7.7 173 
cm), and BMI (B= 1.3; 0.5, 2.0 kg/m2) at follow up after baseline adjustment. 174 
 175 
Discussion  176 
The present study has several key findings. First, healthy obesity is a relatively unstable 177 
phenotype. Second, instability in healthy obesity was not attributable to self-reported 178 
lifestyle behaviours including physical activity, but we did observe greater increases in waist 179 
circumference that is likely to be reflective of adverse changes in visceral adiposity. Third, 180 
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important features of instability were also development of low grade systemic 181 
inflammation, impaired glycaemic control, and reduction in HDL-cholesterol. 182 
Our findings relating to stability in healthy obesity over time are largely consistent with the 183 
limited available evidence.4,5 However, when one considers defining metabolic health as 184 
“zero risk factors” we observed striking results; first, obese adults without any metabolic 185 
risk factors are rare (10.7% of obese participants); and second, obese adults who maintain 186 
zero risk factors over time are rarer still (2.9% of obese participants). 187 
Only one previous study has examined the characteristics of stable and unstable healthy 188 
obese adults. Consistent with our findings, they showed no differences in self-reported 189 
physical activity, alcohol or smoking,4 although the unstable healthy obese demonstrated 190 
higher waist circumference at baseline. Our results add to this evidence base by showing 191 
that unstable healthy obese adults developed greater increases in central adiposity and 192 
several metabolic risk factors over 8 years follow-up, one particularly notable factor being 193 
impaired glycaemic control. The unstable healthy obese displayed slightly elevated HbA1c 194 
levels at baseline compared with their stable counterparts, but also greater increases in this 195 
risk factor at follow up as our analyses were adjusted for baseline. Previous work has also 196 
demonstrated that weight cycling is associated with metabolic syndrome,9, 10 although this 197 
findings was not replicated in our data possibly owing to limited follow up of body mass 198 
assessments over the 8 years. Several over feeding studies have demonstrated that healthy 199 
obese adults display different biological responses to moderate weight gain, such as 200 
increased adipose tissue capacity for lipogenesis11 and favourable characteristics of 201 
subcutaneous adipose tissue that help prevent visceral fat depots.12 Thus, more subtle 202 
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differences in metabolic function, that were not possible to measure in this study, may 203 
differentiate stable and unstable healthy obesity.  204 
Several limitations should be noted. Participants with poorer metabolic health at baseline 205 
were less likely to complete follow up assessments. Thus, the proportion of unhealthy 206 
participants that transitioned into a healthy metabolic state at follow-up may be over-207 
estimated. The use of self-report measures to assess lifestyle risk factors may have 208 
introduced bias. Indeed, we recently demonstrated differences in physical activity between 209 
healthy and unhealthy obese adults when using objective data but not for self report.13 210 
Thus, the results on self-reported physical activity in the present study may underestimate 211 
the associations, although a major bias is unlikely. 212 
In summary, healthy obesity is a relatively unstable phenotype at high risk of developing 213 
vascular, inflammatory, glycaemic and lipidaemic abnormalities over time. A true healthy 214 
obese phenotype capable of maintaining exceptional metabolic health (zero risk factors) for 215 
a prolonged period appears to be exceptionally rare in the general population. Disease 216 
prevention strategies are therefore required in the healthy obese. 217 
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Figure caption 
Figure 1. Progression of metabolic risk factors over 8 years follow up 
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Table 1. Characteristics of healthy obese adults at baseline who remained healthy (stable) or 
became unhealthy (unstable) at follow-up. 
Baseline characteristics Stable healthy obese 
(n= 135) 
Unstable healthy 
obese (n= 108) 
p-value 
Age (years, ± SD) 61.9 ± 7.1 62.4± 7.4 0.59 
Men (%) 40.0 44.4 0.49 
Vigorous physical activity 
at least once/week (%) 
30.4 37.0 0.54 
Current smoker (%) 7.4 13.0 0.15 
At least one alcoholic 
drink/week (%) 
70.0 65.3 0.62 
Body mass index (kg/m2) 32.7±2.8 32.8±3.3 0.73 
Waist circumference (cm) 102.9 ± 13.2 104.9 ± 13.5 0.24 
Systolic BP (mmHg) 132.2 ± 14.2 134.9 ± 14.9 0.16 
Diastolic BP (mmHg) 77.1± 8.7 76.4 ± 7.7 0.49 
HDL-cholesterol (mmol/l) 1.59±0.31 1.48±0.28 0.005 
Triacylglycerol (mmol/l) 1.41±0.65 1.65±0.68 0.005 
C-reactive protein (log 
unit) 
1.09±0.57 1.19±0.59 0.19 
HbA1C (%) 5.35±0.32 5.51±0.28 0.001 
Zero metabolic risk 
factors (%) 
35.6 20.4 0.01 
Weight cycling 12.7 13.2 0.92 
Metabolic risk factors at 
follow-up† 
  Odds ratio (95% CI)‡ 
[stable (ref) vs. 
unstable]  
High blood pressure (%) 37.0 75.0 8.9 (4.7, 17.0) 
Impaired glycaemic 
control (%) 
5.9 46.3 13.8 (6.1, 31.2) 
Low HDL-C (%) 0.7 11.1 15.9 (1.9, 132.5) 
High triglycerides (%) 11.9 45.4 5.9 (2.9, 12.0) 
16 
 
Inflammation (%) 17.0 53.7 8.6 (4.1, 18.1) 
 
† High blood pressure (clinic BP ≥130/85 mmHg, or hypertension diagnosis, or use of anti-
hypertensive medication), impaired glycaemic control (HbA1c > 6.0% or doctor’s diagnosed 
diabetes), systemic inflammation (C-reactive protein≥ 3mg/l), low HDL cholesterol (<1.03 mmol/l in 
men and <1.30 mmol/l in women), and high triacylglycerol (≥ 1.7 mmol/l). 
‡ Odds ratio (OR) for having each risk factor for stable (ref) vs. unstable healthy obese adults; 
adjusted for age, sex, and baseline risk factor. 
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Table 2. Characteristics of unhealthy obese adults at baseline who remained unhealthy or became 
healthy at follow-up. 
Baseline characteristics Remained unhealthy 
at follow-up (n= 299) 
Became healthy at 
follow-up (n= 90) 
p-value 
Age (years, ± SD) 62.3 ± 7.1 63.0± 7.1 0.38 
Men (%) 39.5 34.4 0.39 
Vigorous physical activity 
at least once/week (%) 
22.7 26.7 0.73 
Current smoker (%) 7.2 10.3 0.59 
At least one alcoholic 
drink/week (%) 
45.8 60.5 0.03 
Body mass index (kg/m2) 34.3 ± 3.7 33.5 ± 3.7 0.10 
Waist circumference (cm) 107.5 ± 16.0 104.9 ± 8.3 0.15 
Weight cycling (%) 9.8 7.5 0.54 
Metabolic risk factors at 
follow-up† 
  Odds ratio (95% CI)‡ 
[Healthy (ref) vs. 
unhealthy]  
High blood pressure (%) 85.3 52.2 6.3 (3.3, 12.2) 
Impaired glycaemic 
control (%) 
62.5 7.8 13.5 (5.5, 13.0) 
Low HDL-C (%) 24.4 2.2 16.8 (3.9, 72.7) 
High triglycerides (%) 56.5 7.8 20.9 (9.2, 47.8) 
Inflammation (%) 54.5 17.8 7.5 (4.0, 13.8) 
† High blood pressure (clinic BP ≥130/85 mmHg, or hypertension diagnosis, or use of anti-
hypertensive medication), impaired glycaemic control (HbA1c > 6.0% or doctor’s diagnosed 
diabetes), systemic inflammation (C-reactive protein≥ 3mg/l), low HDL cholesterol (<1.03 mmol/l in 
men and <1.30 mmol/l in women), and high triglycerides (≥ 1.7 mmol/l). 
‡ Odds ratio (OR) for having each risk factor for remaining unhealthy (ref) vs. becoming healthy 
obese adults; adjusted for age, sex, and baseline risk factor. 
 
 
 
